Live feed08:00:00·121dPRReleasevia QuantisnowAllarity Therapeutics Issues 2025 End of Year CEO Letter to ShareholdersByQuantisnow·Wall Street's wire, on your screen.ALLR· Allarity Therapeutics Inc.Health Care